According to existing literature, CD44 is highly expressed in stem cells from breast cancer (23), gastric cancer (11), and oral squamous cell carcinoma (24), while CD24 is typically expressed at lower levels. Here, CD24 is linked to oral cavity squamous cell carcinoma.